HOME ABOUT CONTACT AVAILABLE ISSUES SUBSCRIBE MEDIA & ADS CONFERENCE CALENDAR
LATEST UPDATES » Vol 21, No 10, September 2017 – Cardiovascular diseases       » Test strips for cancer detection get upgraded with nanoparticle bling       » Smart nano-pesticide to combat soil and water contamination       » China plans to launch "brain project" by year end       » UNAIDS encourages Chinese to produce drugs for Africa       » Korea-Singapore Healthcare Incubator to support Korean firms in Singapore and Southeast Asia       » Nanomaterial wrap for improved tissue imaging      
EDITORIAL
What's coming for 2013?
Still fresh into the New Year, experts from various fields and industries are busy looking into their crystal balls in an attempt to predict what the hot issues for the year will be, which sectors will experience growth, and what will be trending for 2013. The field of life sciences is no different from the next industry.

Above and beyond industry forecasts, there are other anticipated global issues in 2013 that will either directly, or indirectly, affect all businesses. How will 2013 turn out to be, now that President Barack Obama has won a second term in office in the United States? Will he be able to turn the seemingly inevitable fiscal cliff around? Like it or not, developments in the American economy will affect us all β€” across countries and businesses and industries. As such, many MNCs are looking to move their operations and set up base in Asia, after being confronted with shifting business paradigms, anemic sales, fiscal cliffs and flat markets in the West. We are no longer living in an era where the West dictates global developments. Instead, we are seeing the emergence of China, which is projected to become the biggest pharmaceutical market after the United States as soon as 2016. The Economist Intelligence Unit has also found that a local presence in China has translated into success for pharmaceutical companies in the last three years. The real question to ask is: How can one miss out on the Chinese boom?

Another thing that is happening this year - US$290 billion worth of sales are at risk because of patent expirations between 2012 and 2018, according to estimates by pharmaceutical researcher EvaluatePharma. 2013 alone will see the expiration of patents for around 120 drugs that currently have sales of US$29 billion annually, and EvaluatePharma expects that more than 70% of that total will be lost to generics β€” two of the main reasons why generics will be a hot topic for 2013. Ever more so, this is the time pharmaceutical companies need a fresh approach to research and development (R&D) if they wish to tide through the year.

There are many questions that are raised at the start of a new year that we do not have answers to. We aim to address a few of those in this issue that looks into the future. Read on to see what industry players and your fellow researchers have to say about the future of the life sciences in areas like generics and biosimilars β€” which we anticipate will be very hot topics this yearβ€” as with China's growth in the bioscience industry.


Sulastri Kamis
Editor
Asia Pacific Biotech News

Check out our new website at www.asiabiotech.com
Sign up for our mailing list to get updates at www.worldscientific.com/page/newsletter-sign-up
Air your views and suggestions by writing to in to the editorial team (Letters to the Editor) at biotech_edit@wspc.com

Click here for the complete issue.

NEWS CRUNCH  
news Medical technology experts to address the impact of innovation in shaping patient outcomes across Asia Pacific
news China biotech's 'coming out party' masks long road ahead
news SingHealth, Duke NUS and GSK to conduct large-scale big data study on asthma and COPD in Singapore
PR NEWSWIRE  
Asia Pacific Biotech News
EDITORS' CHOICE  

Lady Ganga: Nilza'S Story
COLUMNS  
Subscribe to APBN E-Newsletter
Find us under 'Others' option to receive APBN e-newsletters thrice a month!

APBN Editorial Calendar 2017
January:
Healthcare Focus: LUNGS
February:
War on CANCER
March:
Get to Know TCM
April:
Diabetes: The Big Picture
May:
The Piece of Your Mind - Brain Health/Science
June:
Advocacies in Support of Rare Disease Patients
July:
Food Science & Technology
August:
Eye – the Window to your Soul
September:
Infectious Diseases
October:
A change of heart — Cardiovascular diseases
November:
Diseases threatening our Children
December:
Skin Diseases/Allergic Reactions
Editorial calendar is subjected to changes.
MAGAZINE TAGS
About Us
Events
Available issues
Editorial Board
Letters to Editor
Instructions to Authors
Advertise with Us
CONTACT
World Scientific Publishing Co. Pte. Ltd.
5 Toh Tuck Link, Singapore 596224
Tel: 65-6466-5775
Fax: 65-6467-7667
» For Editorial Enquiries:
   biotech_edit@wspc.com or Ms Lim Guan Yu
» For Subscriptions, Advertisements &
   Media Partnerships Enquiries:
   biotech_ad@wspc.com
Copyright© 2017 World Scientific Publishing Co Pte Ltd  •  Privacy Policy